Roquefort Therapeutics (LON:ROQ) Shares Up 20.5% – What’s Next?

Shares of Roquefort Therapeutics plc (LON:ROQ) were up 20.5% during trading on Monday . The stock traded as high as GBX 6.18 ($0.08) and last traded at GBX 6.18 ($0.08). Approximately 1,275,685 shares changed hands during trading, an increase of 221% from the average daily volume of 397,992 shares. The stock had previously closed at GBX 5.13 ($0.07).

Roquefort Therapeutics Stock Performance

The stock has a market cap of £7.98 million, a P/E ratio of -512.80 and a beta of 0.05. The company has a debt-to-equity ratio of 12.37, a current ratio of 0.79 and a quick ratio of 3.07. The stock’s 50 day simple moving average is GBX 3.78 and its two-hundred day simple moving average is GBX 4.25.

About Roquefort Therapeutics

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.